Cargando…
Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression
SIMPLE SUMMARY: Here, we describe a previously unreported mechanism of PD-1/MET interaction and PD-1 induction of epithelial-to-mesenchymal transition (EMT), which is observed early in pancreatic cancer development and progression. This oncogenic mechanism is distinct from established immune functio...
Autores principales: | Harper, Megan M., Lin, Miranda, Qasem, Shadi A., Patel, Reema A., Cavnar, Michael J., Pandalai, Prakash K., Gao, Mei, Kim, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264908/ https://www.ncbi.nlm.nih.gov/pubmed/35804822 http://dx.doi.org/10.3390/cancers14133051 |
Ejemplares similares
-
Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells
por: Harper, Megan M., et al.
Publicado: (2022) -
An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
por: Lin, Miranda, et al.
Publicado: (2020) -
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
por: Sylvester, Paul W
Publicado: (2014) -
Regulators of epithelial mesenchymal transition in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2012) -
The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)